Exploiting Cholera Vaccines As a Versatile Antigen Delivery Platform

Overview

Journal Biotechnol Lett

Specialties Biochemistry
Biotechnology

Date 2007 Nov 17

PMID 18008168

Citations 5

Authors

Anisia J Silva

Francis O Eko

Jorge A Benitez

Affiliations

Soon will be listed here.

Abstract

The development of safe, immunogenic and protective cholera vaccine candidates makes possible their use as a versatile antigen delivery platform. Foreign antigens can be delivered to the immune system with cholera vaccines by expressing heterologous antigens in live attenuated vectors, as fusion proteins with cholera toxin subunits combined with inactivated Vibrio cholerae whole cells or by exposing them on the surface of V. cholerae ghosts. Progress in our understanding of the genes expressed by V. cholerae during infection creates unprecedented opportunities to develop an improved generation of vaccine vectors to induce immune protection against a broad range of pathogenic organisms.

Citing Articles

The Mutagenic Plasticity of the Cholera Toxin B-Subunit Surface Residues: Stability and Affinity.

Au C, Manfield I, Webb M, Paci E, Turnbull W, Ross J Toxins (Basel). 2024; 16(3).

PMID: 38535799 PMC: 10974167. DOI: 10.3390/toxins16030133.

A Self-Assembling Whole-Cell Vaccine Antigen Presentation Platform.

Liao J, Smith D, Brynjarsdottir J, Watnick P J Bacteriol. 2018; 200(15).

PMID: 29483163 PMC: 6040178. DOI: 10.1128/JB.00752-17.

Live bacterial vaccine vectors: an overview.

da Silva A, Zangirolami T, Novo-Mansur M, de Campos Giordano R, Martins E Braz J Microbiol. 2015; 45(4):1117-29.

PMID: 25763014 PMC: 4323283. DOI: 10.1590/s1517-83822014000400001.

Attenuation of bacterial virulence by quorum sensing-regulated lysis.

Silva A, Benitez J, Wu J J Biotechnol. 2010; 150(1):22-30.

PMID: 20673838 PMC: 2974442. DOI: 10.1016/j.jbiotec.2010.07.025.

Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103-HgR.

Morin C, Kaper J FEMS Immunol Med Microbiol. 2009; 57(1):69-79.

PMID: 19678844 PMC: 2906245. DOI: 10.1111/j.1574-695X.2009.00580.x.

References

Osorio C, Crawford J, Michalski J, Martinez-Wilson H, Kaper J, Camilli A . Second-generation recombination-based in vivo expression technology for large-scale screening for Vibrio cholerae genes induced during infection of the mouse small intestine. Infect Immun. 2005; 73(2):972-80. PMC: 546989. DOI: 10.1128/IAI.73.2.972-980.2005. View

Benitez J, Garcia L, Silva A, Garcia H, Fando R, Cedre B . Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate. Infect Immun. 1999; 67(2):539-45. PMC: 96352. DOI: 10.1128/IAI.67.2.539-545.1999. View

Butterton J, Boyko S, Calderwood S . Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains. Vaccine. 1993; 11(13):1327-35. DOI: 10.1016/0264-410x(93)90103-5. View

Ghorpade A, Garg L . Efficient expression, processing and secretion of a biologically active mammalian protein by Vibrio cholerae. FEBS Lett. 1996; 387(2-3):167-70. DOI: 10.1016/0014-5793(96)00475-9. View

Eko F, Schukovskaya T, Lotzmanova E, Firstova V, Emalyanova N, Klueva S . Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits. Vaccine. 2003; 21(25-26):3663-74. DOI: 10.1016/s0264-410x(03)00388-8. View

Sanchez J, Svennerholm A, Holmgren J . Genetic fusion of a non-toxic heat-stable enterotoxin-related decapeptide antigen to cholera toxin B-subunit. FEBS Lett. 1988; 241(1-2):110-4. DOI: 10.1016/0014-5793(88)81041-x. View

Gentschev I, Dietrich G, Spreng S, Kolb-Maurer A, Brinkmann V, Grode L . Recombinant attenuated bacteria for the delivery of subunit vaccines. Vaccine. 2001; 19(17-19):2621-8. DOI: 10.1016/s0264-410x(00)00502-8. View

Peltola H, Siitonen A, Kyronseppa H, Simula I, Mattila L, Oksanen P . Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet. 1991; 338(8778):1285-9. DOI: 10.1016/0140-6736(91)92590-x. View

Silva A, Benitez J . Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae. FEMS Immunol Med Microbiol. 2005; 43(3):393-8. DOI: 10.1016/j.femsim.2004.10.001. View

10.

Favre D, Ludi S, Stoffel M, Frey J, Horn M, Dietrich G . Expression of enterotoxigenic Escherichia coli colonization factors in Vibrio cholerae. Vaccine. 2006; 24(20):4354-68. DOI: 10.1016/j.vaccine.2006.02.052. View

11.

Rollins S, Peppercorn A, Hang L, Hillman J, Calderwood S, Handfield M . In vivo induced antigen technology (IVIAT). Cell Microbiol. 2004; 7(1):1-9. DOI: 10.1111/j.1462-5822.2004.00477.x. View

12.

Gentschev I, Mollenkopf H, Sokolovic Z, Hess J, Kaufmann S, Goebel W . Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway. Gene. 1996; 179(1):133-40. DOI: 10.1016/s0378-1119(96)00424-6. View

13.

Eko F, He Q, Brown T, McMillan L, Ifere G, Ananaba G . A novel recombinant multisubunit vaccine against Chlamydia. J Immunol. 2004; 173(5):3375-82. DOI: 10.4049/jimmunol.173.5.3375. View

14.

Ryan E, Crean T, Kochi S, John M, Luciano A, Killeen K . Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae. Infect Immun. 1999; 68(1):221-6. PMC: 97124. DOI: 10.1128/IAI.68.1.221-226.2000. View

15.

Ryan E, Crean T, John M, Butterton J, Clements J, Calderwood S . In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae. Infect Immun. 1999; 67(4):1694-701. PMC: 96516. DOI: 10.1128/IAI.67.4.1694-1701.1999. View

16.

Hazra A, Silva A, Benitez J . Expression of foreign proteins in a Vibrio cholerae vaccine strain using the stationary phase hemagglutinin/protease promoter. Biotechnol Lett. 2007; 29(7):1093-7. DOI: 10.1007/s10529-007-9359-9. View

17.

Trucksis M, Galen J, Michalski J, Fasano A, Kaper J . Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci U S A. 1993; 90(11):5267-71. PMC: 46697. DOI: 10.1073/pnas.90.11.5267. View

18.

Pouwels P, Leer R, Boersma W . The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J Biotechnol. 1996; 44(1-3):183-92. DOI: 10.1016/0168-1656(95)00140-9. View

19.

Butterton J, Ryan E, Acheson D, Calderwood S . Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect Immun. 1997; 65(6):2127-35. PMC: 175294. DOI: 10.1128/iai.65.6.2127-2135.1997. View

20.

Kenner J, Coster T, Taylor D, Trofa A, Hyman T, Adams J . Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. J Infect Dis. 1995; 172(4):1126-9. DOI: 10.1093/infdis/172.4.1126. View